retatrutide nejm Research Guide: What the Phase 2 Trial Data Reported (2026) CutKilo | Retatrutide - what
Description
Initial U.S
Clinical trials showed an average weight loss of 11.2% over 16 months at the highest dose
Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A
Chaves Filho, A
Indeed, only 2 months later (September 2023), Intuitive was already fielding worst case scenarios conference questions: People are sitting there worried, well, bariatric is going to slow, I don't know how much because of GLP-1s
Open 6 , e2329178 (2023)
